Drug
Butenafine clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 4
- first study started
- 2008
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 4 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Bayer (4) · Taro Pharmaceuticals USA (2) · United Laboratories (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses butenafine is read from its arms, and is right about nine times in ten.
Testing it · 7
- Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)CompletedPhase 3BayerNCT04531540Written as Butenafine HCl 1% (BAY1896425)
- Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy ParticipantsCompletedPhase 3BayerNCT04532164Written as Butenafine HCl 1% (BAY1896425) - Induction Phase
- Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human SubjectsCompletedPhase 3BayerNCT04531527Written as Butenafine HCl 1% (BAY1896425)
- Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)CompletedPhase 3BayerNCT04531813Written as Butenafine HCl 1% (BAY1896425)
- SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDISStatus unknownPhase 2United LaboratoriesNCT03999437Written as BUTENAFINE HYDROCHLORIDE (1%)
- Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea PedisTerminatedPhase 1Taro Pharmaceuticals USANCT01119742Written as Butenafine Hydrochloride 1%
- Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea PedisCompletedPhase 1Taro Pharmaceuticals USANCT00835510Written as Butenafine cream 1% manufactured by Taro
As the comparator · 1 — what is tested is compared with butenafine
Codes
What other systems call butenafine · ClinicalTrials.gg INT003554
- MeSH (NLM) C067594butenafineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 91Y494NL0XBUTENAFINEConfirmed FDA, NLM, Wikidata
- RxNorm 47461Confirmed FDA, Wikidata
- Wikidata Q850729butenafineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72959ButenafineOne source FDA
- DrugBank DB01091One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C067594 | butenafine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 91Y494NL0X | BUTENAFINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 47461 | — | Confirmed FDA, Wikidata |
| Wikidata | Q850729 | butenafine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72959 | Butenafine | One source FDA |
| DrugBank | DB01091 | — | One source Wikidata |
Also registered as butenafine hydrochloride (UNII R8XA2029ZI · RxNorm 236558).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.